This Dividend King is beyond Buffett's reach to fully acquire and is a great pick for income investors.
(Bloomberg) -- Johnson & Johnson’s successful use of a “court-shopping” legal tactic to advance its latest plan for resolving thousands of cancer claims spotlights a controversial bankruptcy maneuver corporations have long employed to avoid unfavorable rulings. Most Read from BloombergThe Master Plan That Shaped Pakistan’s Capital Is No Longer WorkingThe Cablebus Transformed Commutes in Mexico City’s Populous OutskirtsAs Brussels Booms, an Old Boogeyman Returns: BrusselizationChicago Marathon to
We recently made a list of Goldman Sachs’ List Of Stocks Popular With Mutual Fund Managers: Top 20 Stocks. In this piece, we will look at where Johnson & Johnson (NYSE:JNJ) ranks among the list of stocks that mutual funds are buying according to Goldman Sachs. As the fourth quarter of 2024 starts, the market […]